📊 WGRX Key Takeaways
Is Wellgistics Health, Inc. (WGRX) a Good Investment?
Wellgistics Health exhibits severe financial distress with negative stockholders' equity of -$15.1M indicating technical insolvency. The company is experiencing critical liquidity crisis (0.09x current ratio, $51.7K cash) while burning $3.4M quarterly in operations, making near-term solvency highly questionable despite 28.7% revenue growth.
Wellgistics Health, Inc. Key Strengths (WGRX)
- Revenue growth of 28.7% YoY demonstrates market demand for products
- Positive gross profit ($170.2K) indicates viable unit economics at product level
- Low revenue base ($1.6M) leaves room for improvement if operational losses are arrested
WGRX Stock Risks: Wellgistics Health, Inc. Investment Risks
- Negative stockholders' equity of -$15.1M signals technical insolvency; liabilities exceed assets by $15.1M
- Critical liquidity failure: current ratio 0.09x, quick ratio 0.03x, only $51.7K cash available
- Operating cash burn of -$3.4M quarterly with accelerating net losses (-1377.1% YoY) unsustainable
- Debt burden of $27.8M cannot be serviced with current cash generation; maturity risk imminent
- Operating margin of -385.7% indicates structural unprofitability requiring existential restructuring
Key Metrics to Watch
- Quarterly cash runway and monthly operating cash burn rate trajectory
- Debt refinancing progress or restructuring negotiations with lenders
- Revenue-to-operating-expense ratio improvement and path to operating cash flow breakeven
- Stockholders' equity recovery and changes in liquidity ratios (current/quick ratio floor)
- Any capital infusions, dilutive financing, or covenant violations
Wellgistics Health, Inc. (WGRX) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
WGRX Profit Margin, ROE & Profitability Analysis
WGRX vs Market Sector: How Wellgistics Health, Inc. Compares
How Wellgistics Health, Inc. compares to Market sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Wellgistics Health, Inc. Stock Overvalued? WGRX Valuation Analysis 2026
Based on fundamental analysis, Wellgistics Health, Inc. has mixed fundamental signals relative to the Market sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Wellgistics Health, Inc. Balance Sheet: WGRX Debt, Cash & Liquidity
WGRX Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Wellgistics Health, Inc.'s revenue has grown significantly by 29% over the 5-year period, indicating strong business expansion. The most recent EPS of $-0.15 indicates the company is currently unprofitable.
WGRX Revenue Growth, EPS Growth & YoY Performance
WGRX Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $1.6M | -$7.7M | $-0.07 |
| Q3 2025 | $3.0M | -$83.1K | $-0.04 |
| Q2 2025 | $44.5K | -$83.1K | $-0.01 |
| Q1 2025 | $10.9M | -$83.1K | $0.00 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Wellgistics Health, Inc. Dividends, Buybacks & Capital Allocation
WGRX SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Wellgistics Health, Inc. (CIK: 0002030763)
📋 Recent SEC Filings
❓ Frequently Asked Questions about WGRX
What is the AI rating for WGRX?
Wellgistics Health, Inc. (WGRX) has an AI grade of D with 88% confidence, based on fundamental analysis of SEC EDGAR filings.
What are WGRX's key strengths?
Claude: Revenue growth of 28.7% YoY demonstrates market demand for products. Positive gross profit ($170.2K) indicates viable unit economics at product level.
What are the risks of investing in WGRX?
Claude: Negative stockholders' equity of -$15.1M signals technical insolvency; liabilities exceed assets by $15.1M. Critical liquidity failure: current ratio 0.09x, quick ratio 0.03x, only $51.7K cash available.
What is WGRX's revenue and growth?
Wellgistics Health, Inc. reported revenue of $1.6M.
Does WGRX pay dividends?
Wellgistics Health, Inc. does not currently pay dividends.
Where can I find WGRX SEC filings?
Official SEC filings for Wellgistics Health, Inc. (CIK: 0002030763) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is WGRX's EPS?
Wellgistics Health, Inc. has a diluted EPS of $-0.07.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is WGRX's fundamental grade?
Based on our AI fundamental analysis in June 2026, Wellgistics Health, Inc. has a D grade with 88% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is WGRX stock overvalued or undervalued?
Valuation metrics for WGRX: ROE of N/A (sector avg: 15%), net margin of -496.5% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is WGRX's AI grade for 2026?
Our dual AI analysis gives Wellgistics Health, Inc. a combined D grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is WGRX's free cash flow?
Wellgistics Health, Inc.'s operating cash flow is $-3.4M, with capital expenditures of N/A. FCF margin is -218.9%.
How does WGRX compare to other Market stocks?
Vs Default sector averages: Net margin -496.5% (avg: 12%), ROE N/A (avg: 15%), current ratio 0.09 (avg: 1.8).